Avedro Announces CE Mark for its Newest Riboflavin Formulations

Avedro has announced that it has expanded its portfolio of proprietary riboflavin formulations for corneal collagen cross-linking. When used in conjunction with Avedro’s KXL system, these new formulations further reduce the time required to perform cross-linking and in some applications improve cross-linking utility.
MarketWatch